growth hormone releasing hormone analogue
Tesamorelin dose
Answer
FDA label for EGRIFTA WR: The recommended dosage of EGRIFTA WR is 1.28 mg subcutaneously once daily.
Not dosing advice.
FDA LABEL
What the approved labels state
EGRIFTA WR BLA022505 · label of 2026-07-29 Regulator
The recommended dosage of EGRIFTA WR is 1.28 mg subcutaneously once daily.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.